1. ACTR-26. SAFETY AND EFFICACY OF BEVACIZUMAB PLUS TTFIELDS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): DATA FROM A PHASE II CLINICAL TRIAL. (11th November 2019) Authors: Fallah, Jaleh; Chaudhary, Rekha; Rogers, Lisa; (Auston) Wei, Wei; Brewer, Cathy; Peereboom, David; Ahluwalia, Manmeet Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-43. GENOMIC ANALYSIS OF RESPONDERS OF PHASE II TRIAL OF TEMOZOLOMIDE AND TRC-102 (BASE EXCISION REPAIR INHIBITOR) IN BEVACIZUMAB-NAÏVE GLIOBLASTOMA AT FIRST RECURRENCE. (11th November 2019) Authors: Ahluwalia, Manmeet; Dhruv, Harshil; Fallah, Jaleh; Berens, Michael; Drappatz, Jan; Ye, Xiaobu; Lesser, Glenn; Cloughesy, Timothy; Walbert, Tobias; Holdhoff, Matthias; Peereboom, David; Nabors, Louis; Wen, Patrick; Grossman, Stuart; Rogers, Lisa Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. (9th November 2020) Authors: Rauf, Yasmeen; Peereboom, David; Fallah, Jaleh; Schilero, Cathy; Lackner, Pamela; Stevens, Glen; Ahluwalia, Manmeet Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base. Issue 1 (1st January 2019) Authors: Fallah, Jaleh; Olszewski, Adam J. Journal: Hematology Issue: Volume 24:Issue 1(2019) Page Start: 378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Human immunodeficiency virus‐associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base. Issue 17 (23rd June 2016) Authors: Olszewski, Adam J.; Fallah, Jaleh; Castillo, Jorge J. Journal: Cancer Issue: Volume 122:Issue 17(2016) Page Start: 2689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NCOG-30. ADJUVANT VERSUS SALVAGE MANAGEMENT FOR IDH-MUTANT LOW GRADE GLIOMA. (9th November 2020) Authors: Tom, Martin; Park, Deborah; Tewari, Surabhi; Wei, Wei; Chao, Samuel; Yu, Jennifer; Suh, John; Ahluwalia, Manmeet; Peereboom, David; Stevens, Glen; Fallah, Jaleh; Prayson, Richard; Barnett, Gene; Angelov, Lilyana; Mohammadi, Alireza; Murphy, Erin Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. RBTT-08. A RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA (GBM). (11th November 2019) Authors: Ahluwalia, Manmeet; Fallah, Jaleh; Peereboom, David; Schilero, Cathy; Ali, Assad; Forst, Deborah; Wong, Eric; Wen, Patrick; Reardon, David Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials. Issue 9 (September 2021) Authors: Fallah, Jaleh; Zhang, Lijun; Amatya, Anup; Gong, Yutao; King-Kallimanis, Bellinda; Bhatnagar, Vishal; Weinstock, Chana; Suzman, Daniel L; Agrawal, Sundeep; Chang, Elaine; Anscher, Mitchell S; Chi, Dow-Chung; Xu, James X; Brewer, Jamie R; Brave, Michael H; Hadadi, Mehrnoosh; Theoret, Marc R; Kluet... Journal: Lancet oncology Issue: Volume 22:Issue 9(2021) Page Start: 1230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Variation in the use of up‐front chemotherapy for indolent B‐cell lymphomas and chronic lymphocytic leukemia. Issue 4 (16th December 2016) Authors: Fallah, Jaleh; Olszewski, Adam J. Journal: Hematological oncology Issue: Volume 35:Issue 4(2017:Dec.) Page Start: 921 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗